Summary and Recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The Fifth International Workshop-Conference on Gestational Diabetes Mellitus (GDM) was held in Chicago, IL, 11–13 November 2005 under the sponsorship of the American Diabetes Association. The meeting provided a forum for review of new information concerning GDM in the areas of pathophysiology, epidemiology, perinatal outcome, long-range implications for mother and her offspring, and management strategies. New information and recommendations related to each of these major topics are summarized in the report that follows. The issues regarding strategies and criteria for the detection and diagnosis of GDM were not reviewed or discussed in detail, since it is anticipated that the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study will provide data in mid-2007 that will foster the development of criteria for the diagnosis of GDM that are based on perinatal outcomes. Thus, for the interim, the participants of the Fifth International Workshop-Conference on GDM endorsed a motion to continue use of the definition, classification criteria, and strategies for detection and diagnosis of GDM that were recommended at the Fourth Workshop-Conference. Those guidelines are reproduced (with minor modifications) in this article in appendix Tables 1 and 2. The invited lectures, topical discussions, and posters presented at the conference and the invited manuscripts that appear in this issue of Diabetes Care served as the basis for the following summary and recommendations. ### Pathophysiology #### General considerations. Current diagnostic criteria assign the diagnosis of GDM to women with glucose levels in the upper ∼5–10% of the population distribution. The hyperglycemia varies in severity from glucose concentrations that would be diagnostic of diabetes outside of pregnancy to concentrations that are asymptomatic and only slightly above normal, but associated with some increased risk of fetal morbidity. Like all forms of hyperglycemia, GDM is characterized by insulin levels that are insufficient to meet insulin demands. The causes of pancreatic β-cell dysfunction that …
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The higher diagnosis of GDM in the one-step approach can lead to more resource utilization for subsequent maternal treatment and fetal monitoring.55,59,66”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [66]
In the citing paper
“Epidemiological studies of risk factors for GDM are limited and are typically afflicted by confounding factors [26,27].”
From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [27]
In the citing paper
“In a multiethnic U.S. population, Ferrara et al. (16) found risk of severe macrosomia, neonatal hypoglycemia, and hyperbilirubinemia increased with increasing number of abnormal glucose values according to current American Diabetes Association cut points (2,5) among women who did not meet National Diabetes Data Group criteria for GDM (31).”
From International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy (2010) · cites this paper as [5]
In the citing paper
“These criteria were chosen to identify women at high risk for development of diabetes after pregnancy (5) or were derived from criteria used for nonpregnant individuals (6) and not necessarily to identify pregnancies with increased risk for adverse perinatal outcome.”
From International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy (2010) · cites this paper as [5]
Citations
Cites
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Criteria for screening tests for gestational diabetes
Carpenter, M. W., & Coustan, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90349-0 · Cited by 1,924
Self-citationA comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2006) · Diabetes Care · doi:10.2337/diacare.29.s1.06.s43 · Cited by 924
Third-Trimester Maternal Glucose Levels From Diurnal Profiles in Nondiabetic Pregnancies
Parretti, E., Mecacci, F., Papini, M., Cioni, R., Carignani, L., Mignosa, M., La Torre, P., & Mello, G. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1319 · Cited by 178
Diurnal glycemic profile in obese and normal weight nondiabetic pregnant women
Yogev, Y., Ben-Haroush, A., Chen, R., Rosenn, B., Hod, M., & Langer, O. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.06.059 · Cited by 168
Self-citationSchaefer-Graf, U. M., Hartmann, R., Pawliczak, J., Passow, D., Abou-Dakn, M., Vetter, K., & Kordonouri, O. (2006) · Diabetes Care · doi:10.2337/dc05-2413 · Cited by 89
Research works printed but not linked: 1
- Metzger BE, Coustan DR, the Organizing Committee: Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 21 (Suppl. 2):161–167, 1998
Cited by
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Metadata
- Authors
- Metzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., Pettitt, D. J., Sacks, D. A., & Zoupas, C.
- Affiliations
- Northwestern University (US)
- University of Southern California (US)
- Women & Infants Hospital of Rhode Island (US)
- Department of Endocrinology, Hospital de la Santa Creui Sant Pau, Universitat Autònoma, Barcelona, Spain
- University of Cambridge (GB)
- Royal Victoria Hospital (GB)
- Tel Aviv University (IL)
- Division of Maternal-Fetal Medicine, Santa Clara County Health System, San Jose, California
- University of California, Los Angeles (US)
- Division of Maternity Services, The Royal Women's Hospital, Carlton, Victoria, Australia
- Sansum Diabetes Research Institute (US)
- Kaiser Foundation Hospital (US)
- Hygeia Hospital (GR)
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-07-01
- Volume
- 30
- Issue
- Supplement_2
- Pages
- S251-S260
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2119552042
- Cited by
- 1,908
- References
- 7
- Citations by year
- 2026: 14 · 2025: 41 · 2024: 38 · 2023: 57 · 2022: 63 · 2021: 68 · 2020: 78 · 2019: 92 · 2018: 98 · 2017: 144 · 2016: 105 · 2015: 130 · 2014: 122 · 2013: 118 · 2012: 116
- FWCI
- 129.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- gestational diabetes mellitus, pathophysiology, insulin resistance, beta-cell dysfunction, perinatal outcomes, fetal morbidity, GDM management, HAPO study
- MeSH terms
- Birth Weight, Blood Glucose, Cardiovascular Diseases, Female, Humans, Hypoglycemic Agents, Motor Activity, Placenta, Pregnancy, Risk Factors, Diabetes, Gestational, Delivery, Obstetric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.